PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹176 Cr | ₹437 Cr | ₹548 Cr | ₹467 Cr |
What is the latest Contingent Liabilities ratio of PFIZER ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹437 Cr |
| Mar2022 | ₹548 Cr |
| Mar2021 | ₹467 Cr |
How is Contingent Liabilities of PFIZER Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -11.64 | |
| Mar2024 | ₹176 Cr | -59.62 | |
| Mar2023 | ₹437 Cr | -20.37 | |
| Mar2022 | ₹548 Cr | 17.47 | |
| Mar2021 | ₹467 Cr | - | |
Compare Contingent Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,569.3 Cr | 3.7% | -8.3% | 14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 3.7% |
-8.3% |
14.4% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses